Condition
Thoracic Tumors
Total Trials
6
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (2)
Trial Status
Recruiting4
Withdrawn1
Not Yet Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT02941458RecruitingPrimary
Thoracic Tumours Register
NCT06333951Phase 1RecruitingPrimary
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
NCT06840288RecruitingPrimary
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
NCT07154355Not ApplicableRecruiting
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
NCT05165498Not Yet Recruiting
Real-time Ultrasound Guidance for Thoracic Epidural Blocks
NCT04841538Phase 1WithdrawnPrimary
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors
Showing all 6 trials